Pancreatic Disorders News

The American Society for Clinical Pathology has added five recommendations for laboratory treatments and tests that physicians and patients should question, according to a press release from the organization.

Screening adults with new-onset diabetes for pancreatic cancer may be effective for early diagnosis and treatment initiation, according to study data presented at the 52nd European Association for the Study of Diabetes Annual Meeting.

Endoscopic ultrasound with fine needle aspiration has “incremental value” over imaging techniques like computer tomography and MRI for identifying malignant branch-duct intraductal papillary mucinous neoplasms, according to retrospective study data.

The WHO’s International Agency for Research on Cancer working group identified an additional eight types of cancer associated with excess body fatness, including multiple myeloma; meningioma; and cancers of the gastric cardia, liver, gallbladder, pancreas, ovary and thyroid.

Acute pancreatitis is the most common pancreatic disease in the world and pancreatic cancer is the most deadly, but the incidence and mortality of major pancreatic diseases varies significantly throughout different geographical regions, according to the results of a meta-analysis published in the Lancet Gastroenterology and Hepatology.

Among incretin-based drugs for managing type 2 diabetes mellitus, glucagon-like peptide 1 agonists are associated with an increased risk for bile duct and gallbladder disease, but are not associated with an increased risk for acute pancreatitis compared with other oral antidiabetic drugs, according to study results published in JAMA Internal Medicine.

The benefit of acute pancreatitis severity scores remains uncertain due to test characteristics and clinical utility, according to findings published in the Annals of Internal Medicine.

The FDA granted an orphan drug designation to Araim Pharmaceuticals for its Innate Repair Receptor activator ARA 290, according to a press release.

CHICAGO — Rucaparib showed clinical efficacy in a small cohort of patients with pancreatic cancer and BRCA mutations, according to a poster presented at ASCO 2016.

SAN DIEGO — In this exclusive video from DDW 2016, outgoing AGA President Michael Camilleri, MD, from the Mayo Clinic in Rochester, Minn., discusses two abstracts presented during the AGA Presidential Plenary that show promise for using genetic markers to improve the diagnosis of pancreatic cysts.